Skip to main content

Protect Pharmaceutical Corp. Announces New Assets, Leadership and Plans For Full Audit

Written by Customer Service on . Posted in Public Companies.

Istanbul, Turkey, April 10, 2023 (GLOBE NEWSWIRE) — Protect Pharmaceutical Corp. “OTC:(PRTT)” announces the completion of the recent appointment of Ali Yildiz as President and the finalization of the acquisition of Antarax Capital Danismanlik Limited.

With the filing of the new company financials on the OTC Markets website, this completes the initial introduction of an enhanced Protect Pharmaceutical Corp. to our shareholders and the public markets.

The company President Mr. Yildiz has been involved in multiple acquisitions in the past and stated that he is very excited to move forward with Protect Pharmaceutical, Corp and Antarax Limited.

With OTC filings now complete the company intends to interview and find an auditor to complete a full audit. The company had revenues of over 90 million dollars in 2022 and expects to see modest growth in 2023 to both revenue and profitability. Mr Yildiz stated, “As we retain an auditor and move towards our future goals it is our intent to provide regular shareholder updates with our progress.”

About Antarax Limited:

Antarax Capital Danismanlik limited operates a logistics business providing Air, sea and land transportation and customs warehousing and storage for goods in transit. Antarax will provide future updates and details of our operations and expansion goals in future updates with shareholders.

Forward-Looking Statements: This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as “may”, “will”, “to”, “plan”, “expect”, “believe”, “anticipate”, “intend”, “could”, “would”, “estimate,” or “continue”, or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risk, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date hereof. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company’s filings with OTC Markets. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

For more information contact:
Protect Pharmaceutical Corp.
business@inaiapp.com
+13476928942

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.